Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 163,152	$ 322,536
Marketable securities	180,870
Accounts receivable, net of reserves of $5,404 in 2015 and $4,306 in 2014	199,444	152,380
Inventories	184,500	160,342
Deferred income tax assets	37,509	37,689
Other current assets, net	67,559	86,451
Total current assets	833,034	759,398
Long-Term Assets:
Property and equipment, net	326,041	303,587
Goodwill	179,705	184,450
Intangible assets, net	57,517	65,122
Other long-term assets, net	81,073	71,654
Total long-term assets	644,336	624,813
TOTAL ASSETS	1,477,370	1,384,211
Current Liabilities:
Accounts payable	58,212	44,743
Accrued liabilities	190,441	195,351
Line of credit	498,000	549,000
Current portion of deferred revenue	28,775	31,812
Total current liabilities	775,428	820,906
Long-Term Liabilities:
Deferred income tax liabilities	39,261	41,688
Long-term debt	598,925	350,000
Long-term deferred revenue, net of current portion	23,871	21,665
Other long-term liabilities	31,334	32,363
Total long-term liabilities	693,391	445,716
Total liabilities	$ 1,468,819	$ 1,266,622
Commitments and Contingencies (Note 14)
Stockholders' Equity:
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 102,347 and 101,947 shares in 2015 and 2014, respectively; Outstanding: 92,636 and 47,373 shares in 2015 and 2014, respectively	$ 10,235	$ 10,195
Additional paid-in capital	921,678	888,293
Deferred stock units: Outstanding: 240 and 235 units in 2015 and 2014, respectively	5,376	5,066
Retained earnings	231,070	1,675,299
Accumulated other comprehensive loss	(22,275)	(8,071)
Treasury stock, at cost: 9,711 and 54,574 shares in 2015 and 2014, respectively	(1,137,616)	(2,453,266)
Total IDEXX Laboratories, Inc. stockholders' equity	8,468	117,516
Noncontrolling interest	83	73
Total stockholders' equity	8,551	117,589
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,477,370	$ 1,384,211